ea0044p135 | Neoplasia, cancer and late effects | SFEBES2016
Abraham Stalin
, Casey Ruth
, Challis Ben
, Pitfield Deborah
, Whitley S
, Shaw Ashley
, Heard Sarah
, Saad Zia
, Buscombe John
, Simpson Helen
Peptide receptor radionuclide therapy (PRRT) is a targeted therapy using synthetic somatostatin analogues attached to a radionuclide, which binds to tumours expressing somatostatin receptors. The aim was to review the role of PRRT in a tertiary referral centre. We retrospectively reviewed a cohort of 25 patients (eight males, 17 females), with a median age of 65, who received Yttrium-90 DOTATATE or Lutetium-177 DOTATATE at Addenbrookes Hospital. The location of the primary tum...